| 1 | 155944-23-3 | ZM 230487 | ZM 230487 | C24H26FNO4
| | |
| 2 | 93957-54-1 | 富伐他丁 | Fluvastatin | C24H26FNO4
| 原料;细胞生物学试剂 | |
| 3 | | 3R,-5S-氟伐他汀 | (3R,5S) Fluvastatin | C24H26FNO4
| | |
| 4 | 2249799-34-4 | (3S,5R)-Fluvastatin D6 | (3S,5R)-Fluvastatin D6 | C24H26FNO4
| | |
| 5 | 779995-42-5 | Fluvastatin EP Impurity C | Fluvastatin EP Impurity C | C24H26FNO4
| 杂质对照品;氟伐他汀杂质 | |
| 6 | 93957-58-5 | 氟伐他汀EP杂质A-G | Fluvastatin EP impurity A -G | C24H26FNO4
| 杂质对照品;氟伐他汀杂质;对照品-杂质对照品 | |
| 7 | 155229-76-8 | (-)-3S,5R-氟伐他汀钠盐 | (-)-3S,5R-FLUVASTATIN SODIUM SALT | C24H26FNO4
| | |
| 8 | | FLUVASTATIN FOR SYSTEM SUITABILITY | Fluvastatin for system suitability | C24H26FNO4
| | |
| 9 | | 氟伐他汀降解产物(非对映混合物) | Fluvastatin Degradation Product (diastereomeric mixture) | C24H26FNO4
| | |
| 10 | 1212316-84-1 | N-[2-(4-fluorophenyl)ethyl]-2-[(4-oxo-3,4-dihydrospiro[chromene-2,1'-cyclohexan]-7-yl)oxy]acetamide | N-[2-(4-fluorophenyl)ethyl]-2-[(4-oxo-3,4-dihydrospiro[chromene-2,1'-cyclohexan]-7-yl)oxy]acetamide | C24H26FNO4
| | |
| 11 | 174956-43-5 | 氟伐他汀EP杂质A | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5R,6E)-rel- | C24H26FNO4
| | |
| 12 | | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) | C24H26FNO4
| | |